-
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Bioorganic & medicinal chemistry letters 20130801
-
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
The Biochemical journal 20130415
-
In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines.
Veterinary and comparative oncology 20120901
-
Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy.
Veterinary and comparative oncology 20120901
-
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.
European journal of haematology 20120701
-
NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation.
Allergy 20120701
-
Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.
Veterinary and comparative oncology 20120601
-
Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.
Investigational new drugs 20120401
-
Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting.
Molecular immunology 20120401
-
Stevens-Johnson Syndrome induced by masitinib.
Acta dermato-venereologica 20120301
-
Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses.
Journal of veterinary pharmacology and therapeutics 20120201
-
[KIT and KIT: from biology to clinical use].
Bulletin du cancer 20120201
-
Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study.
Veterinary journal (London, England : 1997) 20120101
-
The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma.
International archives of allergy and immunology 20120101
-
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
BMC neurology 20120101
-
Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.
Veterinary dermatology 20111201
-
Systemic therapy for advanced gastrointestinal stromal tumors: beyond imatinib.
Journal of surgical oncology 20111201
-
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Nature biotechnology 20111101
-
Comprehensive analysis of kinase inhibitor selectivity.
Nature biotechnology 20111030
-
Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors.
Seminars in oncology 20110401
-
Stratified medicine in selecting biologics for the treatment of severe asthma.
Current opinion in allergy and clinical immunology 20110201
-
Safety of masitinib mesylate in healthy cats.
Journal of veterinary internal medicine 20110101
-
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Alzheimer's research & therapy 20110101
-
Emerging therapies for severe asthma.
BMC medicine 20110101
-
F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors.
ISRN gastroenterology 20110101
-
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.
PloS one 20110101
-
Mast cells as cellular sensors in inflammation and immunity.
Frontiers in immunology 20110101
-
Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.
American journal of hematology 20101201
-
Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
Chemistry & biology 20101124
-
Clinical trial on the efficacy of masitinib in canine IBD.
The Veterinary record 20101106
-
Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.
American journal of veterinary research 20101101
-
Churg and Strauss vasculitis in the course of masitinib treatment: a first report.
Allergy 20100801
-
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer.
Cancer chemotherapy and pharmacology 20100701
-
[Focus on GIST management].
Bulletin du cancer 20100601
-
The complexity of the complicity of mast cells in cancer.
The international journal of biochemistry & cell biology 20100501
-
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
European journal of cancer (Oxford, England : 1990) 20100501
-
Masitinib for the treatment of canine atopic dermatitis: a pilot study.
Veterinary research communications 20100101
-
Drug-induced minimal change nephropathy in a dog.
Journal of veterinary internal medicine 20100101
-
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib.
Biologics : targets & therapy 20100101
-
c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
Arthritis research & therapy 20100101
-
Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model.
PloS one 20100101
-
'Masitinib' is safe and effective for the treatment of canine mast cell tumors.
Journal of veterinary internal medicine 20100101
-
Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11.
BMC cancer 20100101
-
[New drugs for small animals in 2009].
Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 20100101
-
Pharmacokinetics of masitinib in cats.
Veterinary research communications 20091201
-
Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers.
European journal of cancer (Oxford, England : 1990) 20090901
-
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
Allergy 20090801
-
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Arthritis research & therapy 20090101
-
More about masitinib.
Arthritis research & therapy 20090101
-
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
PloS one 20090101
-
Clinically relevant advances in rheumatoid arthritis therapy.
F1000 medicine reports 20090101
-
[Gastrointestinal stromal tumors: molecular aspects and therapeutic implications].
Bulletin du cancer 20080101
-
Masitinib is safe and effective for the treatment of canine mast cell tumors.
Journal of veterinary internal medicine 20080101